4:58PM
Harmonic (HLIT) 10.95 +0.55: Reports Q4 (Dec) loss of $0.15 per share, in line with the Multex consensus of ($0.15) -- note that the First Call consensus was for a net loss of $0.16 per share; revenues rose 8.9% year/year to $56.7 mln vs the $56.3 mln consensus.
4:57PM
Advanced Micro (AMD) 16.70 +0.41: Co announces its intention to commence an offering of $500 mln of Convertible Senior Debentures.
4:56PM
SanDisk Corp (SNDK) 13.63 +0.82: -- Update -- On call, says it is cautiously optimistic about improving performance in 2002 based on following factors (1) very strong Q4 sales in retail channel (2) Industrial/telecom customers showing signs of life (3) price declines appear to be moderating and (4) cost reductions being made to return to positive gross margins... SNDK +2.46 at 16.09
4:56PM
Celera Genomics (CRA) 23.40 +1.10: Company updates guidance on revenues for Y02 (Jun); expects revenues in the range of $125.2-$134.1 mln versus the current consensus estimate for $129.3 mln.
4:54PM
Celera Genomics (CRA) 23.40 +1.10 : Reports Q2 (Dec) loss of $0.29 per share, $0.11 better than the Multex consensus of ($0.40); revenues rose 72.4% year/year to $35.0 mln vs the $34.8 mln consensus; "the most likely range for Celera's fiscal 2002 net cash use remains between $155 and $170 million."
4:52PM
Applied Bio (ABI) 33.74 +0.19: Reports Q2 pro forma EPS of $0.24, in-line with the Multex consensus; revs came in at $411.1 mln, short of the consensus of $427.46 mln. The co guides down FY02 EPS to be in the range of $0.80-$0.90, short of the current consensus of $0.94.
4:50PM Cirrus Logic (CRUS) 17.95 +1.24: Company reports Q3 net loss of $0.21 per share, $0.01 better than the consensus; reports Q3 revenues of $77.0 mln versus the consensus estimate of $73.3 mln; for Q4 expects revenue in the range of $81-$83 mln versus the current consensus
estimate of $76.7 mln; sees Q4 net loss in the range of $0.11-$0.15 per share versus the current consensus estimate for a net loss of $0.16 per share.
4:47PM Inhale Thera (INHL) 15.85 -0.40: Reports Q4 pro forma EPS of $(0.37), $0.01 better than the Multex consensus; revs came in at $24.2 mln, well above consensus of $20.04 mln.
4:43PM Progressive (PGR) 146.99 +0.56: Reports Q4 pro forma EPS of $1.87, $0.05 better than the Multex consensus.
4:43PM Medicis Pharm (MRX) 58.75 +0.15: Reports Q2 (Dec) earnings of $0.47 per share, $0.01 better than the Multex consensus of $0.46; revenues rose 28.2% year/year to $53.0 mln vs the $48.2 mln consensus; "third quarter fiscal year 2002 (for the quarter ending March 31, 2002) revenue guidance of $56.0 million and earnings per share guidance of $0.49 remain unchanged."
4:40PM webMethods (WEBM) 21.77 +1.57: Reports Q3 (Dec) lossof $0.05 per share, $0.12 better than the Multex consensus of ($0.17); Q3 revenues came in at $49.1 mln versus the consensus estimate of $41.7 mln.
4:37PM Polycom (PLCM) 32.93 +2.08: Reports Q4 earnings of $0.16 per share, $0.01 better than consensus. Rev rose 5.6% to $120 mln (consensus $118.2 mln).
4:36PM QLogic (QLGC) 51.02 +2.86: Reports Q3 (Dec) earnings of $0.20 per share, $0.01 better than the Multex consensus of $0.19; reports Q3 revenues of $83.6 mln versus the current consensus estimate of $83.5 mln; no formal guidance issued with report.
4:36PM Immunex (IMNX) 28.85 +1.13: Reports Q4 pro forma EPS of $0.08, in-line with the Multex consensus; revs came in at $277.7 mln vs consensus of $272.92 mln. Sales of their
blockbuster ENBREL drug rose 17% in 2001 to $761.9 mln, and totalled $216.3 for Q4.
4:34PM Silicon Storage (SSTI) 8.09 +0.02: Company reports Q4 earnings ex-items of $0.01 per share, $0.01 worse than the Multex consensus estimate -- note that results were in line with the First Call consensus; reports Q4 revenues of $70.8 mln versus the consensus estimate of $76.9 mln; company warns for Q1; expects operating results ranging between breakeven to a net loss of $0.02 per share; expects revenues to drop 3-5% sequentially versus the current Multex consensus estimate of $72.2 mln.
4:30PM Creative Tech (CREAF) 9.85 +0.20:Reports Q2 (Dec) earnings of $0.36 per share, $0.11 better than the Multex consensus of $0.25; revenues fell 41.2% year/year to $250.9 mln vs the $240.0 mln consensus. No guidance in press release.
4:30PM CYTYC Corp (CYTC) 24.74 +1.29: Reports Q4 pro forma EPS of $0.13, in-line with the Multex consensus; revs rose 11% to $63.3 mln vs consensus of $61.24 mln. US Pap test mkt
share grew to 57%.
4:28PM Natl Instruments (NATI) 36.42 +0.57: Reports Q4 (Dec) earnings of $0.14 per share, $0.01 better than the Multex consensus of $0.13; revenues fell 17.3% year/year to $94.4 mln vs the $92.2 mln consensus; daily order rate for the first quarter was down 12% compared to this time last year. If the order rate remains consistent for the rest of the quarter, revenue in Q1 2002 would be flat sequentially; the current consensus estimate is for revenues of $95.1 mln.
4:27PM Varian Semi (VSEA) 35.48 +2.38: Reports Q1 (Dec) loss of $0.37 per share, $0.02 better than the Multex consensus of ($0.39); revenues fell 65.6% year/year to $77.8 mln which
included $28 mln of royalty/license revenue from LRCX, without which revenues would have been roughly in line with the $49.0 mln consensus. Company guides higher for Q2; sees revenues at $45-55 mln vs Multex consensus of $46 mln.
4:25PM DSP Group (DSPG) 23.22 +0.57: Reports Q4 (Dec) earnings of $0.15 per share, $0.01 better than the Multex consensus of $0.14; reports Q4 revenues of $29.2 mln versus the consensus estimate of $28.7 mln; no formal guidance issued with report.
4:25PM NetScreen Tech (NSCN) 22.55 +0.39: Reports Q1 pro forma EPS of $0.00, $0.01 better than the Multex consensus; revs rose 69% to $29.0 mln vs consensus of $28.0 mln.
4:24PM Roxio (ROXI) 18.05 +1.26: Posts Q3 net of $0.19 a share, $0.04 better than consensus, vs yr-ago EPS of $0.36. Rev rose 31.6% to $36.2 mln, exceeding $33.23 mln consensus. Co reiterates Q4 rev guidance of $33 mln (consensus $34.15 mln).
4:23PM HNC Software (HNCS) 16.98 +0.18: Reports Q4 (Dec) earnings of $0.07 per share, in line with the Multex consensus of $0.07; revenues fell 0.9% year/year to $54.6 mln vs the $55.5 mln consensus.
4:22PM KLA-Tencor (KLAC) 51.50 +3.64: -- Update -- Reports Q2 (Dec) earnings of $0.25, a penny better than the Multex consensus of $0.24; revenues were $404.1 mln vs the consensus of $377.6 mln. Company says that it "observed a major trend this quarter that is favorable for our future growth." No specific guidance in press release.
4:21PM Activision (ATVI) 24.80 +0.40: Reports Q3 EPS of $0.66, up 91% and $0.08 better than the First Call consensus; revs rose 40% to $371.3 mln vs consensus of $325.62 mln. The company raises guidance for FY02 rev/EPS to $765 mln/$0.82 and raises FY03 guidance to $845 mln/$0.94 (vs FY02 consensus of $722.52 mln/$0.73 and FY03 of $815.17 mln/$0.84).
4:20PM SanDisk Corp (SNDK) 13.63 +0.82: Reports Q4 (Dec) loss of $0.23 per share, $0.42 better than the Multex consensus of ($0.65); revenues fell 48.2% year/year to $91.9 mln vs the $66.3 mln consensus.
4:18PM Amgen (AMGN) 58.46 +2.40: --Update-- Epogen and Aranesp sales rose 14% to $609 mln, slightly below consensus of $614 mln. Neupogen sales increased 13% to $353 mln, exceeding $343 mln consensus.
4:15PM Citrix Sys (CTXS) 20.31+0.80: Company reports Q4 earnings of $0.21 per share, $0.01 better than the consensus estimate; reports Q4 revenues of $158 mln versus the consensus estimate of $157 mln.
4:13PM Amgen (AMGN) 58.46 +2.40: Reports Q4 (Dec) earnings of $0.30 per share, $0.01 worse than the Multex and First Call consensus estimates. Co calls results "in line" with guidance.Total rev increased $1.12 bln (consensus $1.077 bln).
4:12PM LSI Logic (LSI) 14.31 +0.36: Company issues upside preannouncement for Q1 (Mar); company expects pro forma net loss of $0.14 per share versus the current consensus estimate for a net loss of $0.20 per share; sees revenue growth between 0-3% sequentially.
4:12PM F5 Networks.. (FFIV) 19.04 -0.10: Reports Q1 pro forma EPS of ($0.08), $0.01 better than Multex consensus; revs came in at $27.0 mln vs consensus of $27.32 mln. Co guides down Q2 projections to EPS of about ($0.04)-($0.06) and rev between $27.5-$29.0 mln, vs rev/EPS ests of $30.47 mln/($0.03). The co expects to achieve break-even or better results in Q3 and deliver "solid sequential gains in subsequent quarters".
4:10PM Broadcom (BRCM) 45.38 +1.83: -- Update -- Reports Q4 (Dec) loss of $0.11, a penny better than the Multex consensus of ($0.12); revenues were $226.8 mln vs the consensus of $221.4 mln. No guidance in press release.
4:09PM Micromuse (MUSE) 12.26 +1.72: Reports Q1 (Dec) earnings of $0.04, in line with the Multex consensus; revenues were $40.0 mln vs the consensus of $40.3 mln. No guidance in press release.
4:07PM Imclone Sys (IMCL) 21.78 +2.63: -- Update -- Stock experienced a late session surge; talk is that run was ignited by a Bloomberg headline indicating that co believes it can refile Erbitux without new studies. Hearing that IMCL has discussed the possibility in the past, and that Bloomberg headline ignited a combination of momentum buying and short covering.
4:07PM Halliburton (HAL) 10.80 +0.55: Reports Q4 (Dec) earnings of $0.33 per share, in line with the Multex consensus of $0.33; revenues were $3.17 bln vs the consensus of $3.17 bln.
4:07PM LSI Logic (LSI) 14.31 +0.36: Company reports Q4 net loss of $0.20 per share, $0.04 better than the consensus estimate; reports Q4 revenues of $406 mln versus the consensus estimate of $409 mln.
4:07PM Avanex (AVNX) 4.25 -0.36: Reports Q2 pro forma EPS of ($0.10), $0.01 better than the Multex consensus; revs came in at $8.3 mln vs consensus of $7.07 mln. Co expects Q3 EPS of about ($0.12) and rev between $9-$10 mln (vs rev/EPS ests of $7.36 mln/($0.11)).
4:06PM Emulex (EMLX) 44.13 +5.53: -- Update -- Company announces that it intends to offer $300 mln in convertible notes in a private placement.
4:05PM Corning Inc (GLW) 8.32 -0.14: Reports Q4 (Dec) loss of $0.28 per share, $0.01 better than the Multex consensus of ($0.29) -- note that the First Call consensus estimate was for a net loss of $0.25 per share; reports Q4 revenues of $974 mln versus the consensus estimate of $984
mln; the company will not provide guidance for its 2002 financial performance at this time, but it will discuss its expectations for the first quarter of 2002 at its investor meeting on Februar 8
